Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Permanent pacemaker treatment in older age groups.

K Breivik, O J Ohm

    Acta Medica Scandinavica
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Is EQ-5D-5L sensitive enough to detect treatment-related changes in health status of prostate cancer patients? A nationwide Norwegian longitudinal study from the prostate cancer registry.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
    Same author

    Perfect health not so perfect after all - a methodological study on patient-reported outcome measures in 2574 patients following percutaneous coronary intervention.

    Health and quality of life outcomes·2025
    Same author

    Psychometric Properties of the Norwegian Version of the Fear of COVID-19 Scale.

    International journal of mental health and addiction·2021
    Same author

    Dynamic modelling of aquatic exposure and pelagic food chain transfer of cyclic volatile methyl siloxanes in the Inner Oslofjord.

    Chemosphere·2012
    Same author

    Reverse remodelling of systolic left ventricular contraction pattern by long term cardiac resynchronisation therapy: colour Doppler shows resynchronisation.

    Heart (British Cardiac Society)·2004
    Same author

    Immediate control of life-threatening digoxin intoxication in a child by use of digoxin-specific antibody fragments (Fab).

    Paediatric anaesthesia·2003
    Same journal

    On hereditary, non-hemolytic bilirubinemia.

    Acta medica Scandinavica·2010
    Same journal

    Infections with leukopenia treated with sulfa compounds.

    Acta medica Scandinavica·2010
    Same journal

    A peculiar conduction disturbance, persisting latently after recovery from complete heart block and disclosed only by electrocardiography following exercise.

    Acta medica Scandinavica·2010
    Same journal

    Titration with Weichbrodt's reagent of serum, particularly in the case of gall-liver diseases.

    Acta medica Scandinavica·2010
    Same journal

    Arthralgia due to nervous causes.

    Acta medica Scandinavica·2010
    Same journal

    Auricular standstill.

    Acta medica Scandinavica·2010
    See all related articles

    Permanent pacemaker implantation is safe for elderly patients over 75, offering symptom relief. While early mortality is higher, long-term prognosis improves, similar to peers after one year.

    Area of Science:

    • Cardiology
    • Geriatrics
    • Biomedical Engineering

    Background:

    • Elderly patients represent a significant portion of pacemaker recipients.
    • Understanding the safety and efficacy of permanent pacemaker treatment in this demographic is crucial.

    Purpose of the Study:

    • To evaluate the morbidity and mortality associated with permanent pacemaker implantation in patients aged 75 and older.
    • To assess the safety and therapeutic benefit of pacemaker treatment in the elderly population.

    Main Methods:

    • Retrospective analysis of 693 patients receiving permanent pacemakers between 1962 and 1981.
    • Focus on 282 patients aged 75 and above, stratified into age groups (75-79, 80-84, 85-93).
    • Follow-up for morbidity and mortality, comparing outcomes to age- and sex-matched populations.

    Related Experiment Videos

    Main Results:

    • Complications occurred in 23% of elderly patients, with no significant difference between age subgroups.
    • Most frequent complications included excessive threshold rise (6%) and infections/skin erosions (4.9%).
    • Mortality was elevated in the first 6-12 months post-implantation compared to controls, with 5-year survival rates of 56%, 32%, and 25% across age groups.

    Conclusions:

    • Cardiac pacemaker treatment is a safe and effective symptom-relieving procedure for the elderly.
    • Prognosis for elderly pacemaker patients becomes comparable to their peers after the initial year.